2022 Participants

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.

The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China.

Capital Grand Est is an asset management company based in Strasbourg – France.
The company manages over €180M.
Capital Grand Est is mainly focused on investing in growing SMEs and promising young Start-Ups located in the eastern part of France.

Pfizer CentreOne® is a global CDMO within Pfizer and a leading supplier of specialty APIs. Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support and long-term supply.

Working together with our customers, we combine our knowledge with open dialogue to solve challenges. For more information, visit www.pfizercentreone.com.

Roche is the world’s largest biotech company and #1 investor into R&D, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the CNS. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. Our Pharma Partnering team provides comprehensive BD and alliance management support for Roche and Genentech’s R&D units and the broader pharmaceutical division. Alongside the broad internal pipeline, external innovation has always been a critical component of our R&D strategy.